Bio Synthesis Inc
- View government funding actions
- Lewisville, TX 750574052
- Phone: 800-227-0627
- Corporate URL: www.biosyn.com
- Estimated Number of Employees: 37
- Estimated Annual Receipts: $4,571,404
- Business Start Date: 1989
- Contact Person: Heidi Fazeli
- Contact Phone: 800-227-0627
- Contact Email: heidi@biosyn.com
- Business Structure:
- Corporate Entity (Not Tax Exempt)
- Business Type:
- Self Certified Small Disadvantaged Business
- For Profit Organization
- Woman Owned Small Business
- Woman Owned Business
- Manufacturer of Goods
- Hispanic American Owned
- Subchapter S Corporation
- Industries Served: All Other Basic Organic Chemical Manufacturing, Medicinal and Botanical Manufacturing, Pharmaceutical Preparation Manufacturing, In-Vitro Diagnostic Substance Manufacturing, Biological Product (except Diagnostic) Manufacturing, All Other Miscellaneous Chemical Product and Preparation Manufacturing, Testing Laboratories, Other Scientific and Technical Consulting Services, Medical Laboratories
- Product Areas: DRUGS AND BIOLOGICALS, MISCELLANEOUS CHEMICAL SPECIALTIES, R&D- MEDICAL: BIOMEDICAL (APPLIED RESEARCH/EXPLORATORY DEVELOPMENT), BIOMEDICAL (APPLIED/EXPLORATORY), BIOMEDICAL (ADVANCED), R&D- MEDICAL: BIOMEDICAL (ADVANCED DEVELOPMENT), R&D- MEDICAL: BIOMEDICAL (COMMERCIALIZED), R&D-BIOMEDICAL-COMERCLIZ, HEALTH SERVICES (BASIC), R&D- MEDICAL: HEALTH SERVICES (BASIC RESEARCH), R&D-HEALTH SVCS-A RES/EXPL DEV, R&D- MEDICAL: HEALTH SERVICES (APPLIED RESEARCH/EXPLORATORY DEVELOPMENT), HEALTH SERVICES (ADVANCED), R&D- MEDICAL: HEALTH SERVICES (ADVANCED DEVELOPMENT), R&D- MEDICAL: HEALTH SERVICES (ENGINEERING DEVELOPMENT), HEALTH SERVICES (ENGINEERING), R&D- MEDICAL: HEALTH SERVICES (COMMERCIALIZED), R&D-HEALTH SVCS-COMERCLIZ, R&D- MEDICAL: SPECIALIZED MEDICAL SERVICES (BASIC RESEARCH), R&D-SPEC MED SVCS-B RES, R&D-SPEC MED SVCS-A RES/EXPL DEV, R&D- MEDICAL: SPECIALIZED MEDICAL SERVICES (APPLIED RESEARCH/EXPLORATORY DEVELOPMENT), R&D-SPEC MED SVCS-ADV DEV, R&D- MEDICAL: SPECIALIZED MEDICAL SERVICES (ADVANCED DEVELOPMENT), R&D- MEDICAL: SPECIALIZED MEDICAL SERVICES (ENGINEERING DEVELOPMENT), R&D-SPEC MED SVCS-ENG DEV, R&D-SPEC MED SVCS-COMERCLIZ, R&D- MEDICAL: SPECIALIZED MEDICAL SERVICES (COMMERCIALIZED), AIDS RESEARCH (BASIC), R&D- MEDICAL: AIDS RESEARCH (BASIC RESEARCH), R&D- MEDICAL: AIDS RESEARCH (APPLIED RESEARCH/EXPLORATORY DEVELOPMENT), AIDS RESEARCH (APPLIED/EXPLORATORY), AIDS RESEARCH (ADVANCED), R&D- MEDICAL: AIDS RESEARCH (ADVANCED DEVELOPMENT), AIDS RESEARCH (ENGINEERING), R&D- MEDICAL: AIDS RESEARCH (ENGINEERING DEVELOPMENT), R&D- MEDICAL: AIDS RESEARCH (COMMERCIALIZED), RDTE/Aids Research - Operational System Develop, OTHER MEDICAL (BASIC), R&D- MEDICAL: OTHER (BASIC RESEARCH), R&D- MEDICAL: OTHER (APPLIED RESEARCH/EXPLORATORY DEVELOPMENT), OTHER MEDICAL (APPLIED/EXPLORATORY), R&D- MEDICAL: OTHER (ADVANCED DEVELOPMENT), OTHER MEDICAL (ADVANCED), OTHER MEDICAL (ENGINEERING), R&D- MEDICAL: OTHER (ENGINEERING DEVELOPMENT), R&D-OTHER MEDICAL-COMERCLIZ, R&D- MEDICAL: OTHER (COMMERCIALIZED)
Sampling of Federal Government Funding Actions/Set Asides
In order by amount of set aside monies.
- $6,000 - Thursday the 12th of July 2012
Agricultural Research Service
USDA ARS MWA 5405
PEPTIDE ANTIBODY PACKAGE - $5,565 - Sunday the 10th of August 2014
National Institutes Of Health
NIH, NIAID DEA OA OFC ACQUISITIONS
DRUGS AND BIOLOGICALS - $4,200 - Saturday the 1st of December 2012
National Institutes Of Health
NIH, NICHD, OD OAM OFC ADMIN MGMT
IGF::OT::IGF OTHER FUNCTIONS: ECONOMY CLASS POLYCLONAL ANTIBODY PRODUCTION WITH 3 RABBITS - $3,665 - Tuesday the 20th of December 2011
Veterans Affairs Department
506-ANN ARBOR
MOG 35-55 PEPTIDE 1 GRAM - $3,655 - Saturday the 16th of August 2014
National Institutes Of Health
NIH, NIAID DEA OA OFC ACQUISITIONS
CUST.PEP.1,MISK...AGVAN-19, 1MG,>95% PURE, QUOTE #: 2011-18613 - $3,400 - Monday the 30th of July 2012
National Institutes Of Health
NIH, NICHD, OD OAM OFC ADMIN MGMT
BIO-SYNTHESIS INC., DR. AJAY SHARMA, BLDG-18T, RM-101. CUSTOM PEPTIDE SYNTHESIS AND ANTIBODY PRODUCTION
© Copyright 2019
The Collier Report published by 1918 Media LLC.
Information displayed in this dossier has been provided through available open source or public sources.
No reliance should be made by readers or Collier Report subscribers.
Funding actions are complicated and do not always represent dollar-for-dollar payments to vendors nor do they represent payments in certain instances.
Requests for the modification of displayed information may be made to help.desk@1918.media.